State Street Corp Dexcom Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Dexcom Inc stock. As of the latest transaction made, State Street Corp holds 16,666,472 shares of DXCM stock, worth $1.21 Billion. This represents 0.05% of its overall portfolio holdings.

Number of Shares

16,666,472

Previous 16,308,682 2.19%

Holding current value

$1.21 Billion

Previous $1.85 Billion 39.59%

% of portfolio

0.05%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $22.9 Million - $41.5 Million	357,790 Added 2.19%	16,666,472 $1.12 Billion
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $10.4 Million - $13.2 Million	93,864 Added 0.58%	16,308,682 $1.85 Billion
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $1.85 Million - $2.27 Million	16,220 Added 0.1%	16,214,818 $2.25 Billion
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $12.3 Million - $20.3 Million	163,139 Added 1.02%	16,198,598 $2.01 Billion
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $43.7 Million - $70 Million	-507,633 Reduced 3.07%	16,035,459 $1.5 Billion
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $44.9 Million - $52.3 Million	399,376 Added 2.47%	16,543,092 $2.13 Billion
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $31.5 Million - $37.3 Million	-303,271 Reduced 1.84%	16,143,716 $1.88 Billion
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $4.7 Million - $6.78 Million	55,275 Added 0.34%	16,446,987 $1.86 Billion
Q3 2022 Nov 15, 2022	BUY	$76.35 - $94.18 $12 Million - $14.8 Million	156,880 Added 0.97%	16,391,712 $1.32 Billion
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $830 Million - $1.62 Billion	12,214,959 Added 303.86%	16,234,832 $1.21 Billion
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $2.53 Million - $3.5 Million	-26,909 Reduced 0.66%	4,019,873 $2.06 Billion
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $17.3 Million - $21.7 Million	133,539 Added 3.41%	4,046,782 $2.17 Billion
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $5.81 Million - $7.8 Million	54,464 Added 1.41%	3,913,243 $2.14 Billion
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $7.02 Million - $9.36 Million	86,690 Added 2.3%	3,858,779 $1.65 Billion
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $7.61 Million - $9.4 Million	-89,728 Reduced 2.32%	3,772,089 $1.36 Billion
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $5.08 Million - $6.81 Million	-65,166 Reduced 1.66%	3,861,817 $1.43 Billion
Q3 2020 Nov 10, 2020	BUY	$95.51 - $112.95 $3.71 Million - $4.39 Million	38,862 Added 1.0%	3,926,983 $1.62 Billion
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $115 Million - $194 Million	1,837,985 Added 89.65%	3,888,121 $1.58 Billion
Q1 2020 May 11, 2020	BUY	$47.79 - $75.63 $98 Million - $155 Million	2,050,136 New	2,050,136 $552 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Dexcom Inc Transaction History